BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 21111550)

  • 1. Aspirin in the primary prevention of cardiovascular disease.
    Galloway CF; Stevenson JC
    Maturitas; 2011 Jan; 68(1):3-4. PubMed ID: 21111550
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials.
    Berger JS; Lala A; Krantz MJ; Baker GS; Hiatt WR
    Am Heart J; 2011 Jul; 162(1):115-24.e2. PubMed ID: 21742097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose aspirin for everyone?
    Johns Hopkins Med Lett Health After 50; 2002 Oct; 14(8):4-5. PubMed ID: 12425276
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aspirin use in patients with diabetes mellitus].
    Sicras Mainar A; Ruiz Riera R; Frías Garrido X; Navarro Artieda R
    Med Clin (Barc); 2004 Jul; 123(6):237; author reply 239. PubMed ID: 15282081
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
    Schnell O; Erbach M; Hummel M
    Diab Vasc Dis Res; 2012 Oct; 9(4):245-55. PubMed ID: 22508698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New guidelines refine aspirin prescription. Task force offers recommendation for women and guidance on dosage.
    Harv Heart Lett; 2009 Jun; 19(10):4-5. PubMed ID: 19681207
    [No Abstract]   [Full Text] [Related]  

  • 7. Appropriate aspirin use for primary prevention of cardiovascular disease.
    Miser WF
    Am Fam Physician; 2011 Jun; 83(12):1380-6. PubMed ID: 21671538
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
    Rodondi N; Bauer DC
    Am J Med; 2004 Oct; 117(7):528-30. PubMed ID: 15464713
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aspirin as primary prevention for diabetic patients].
    Fumeaux D; Becerra ME; Philippe J; Louis-Simonet M
    Rev Med Suisse; 2010 Feb; 6(234):244-8. PubMed ID: 20334083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on aspirin. People with heart disease should take aspirin; the decision is trickier for those without it.
    Harv Heart Lett; 2011 Aug; 21(12):3. PubMed ID: 21991607
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
    Klomp CM; ten Cate H; Stehouwer CD; Schaper NC
    Ned Tijdschr Geneeskd; 2009; 153():A109. PubMed ID: 19785798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin increases mortality in diabetic patients without cardiovascular disease: a Swedish record linkage study.
    Welin L; Wilhelmsen L; Björnberg A; Odén A
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1143-9. PubMed ID: 19672841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aspirin in cardiovascular prevention: does the approach differ by gender?].
    Temizhan A
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():2-4. PubMed ID: 18160359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2002 May; 65(10):2107-10. PubMed ID: 12046780
    [No Abstract]   [Full Text] [Related]  

  • 15. Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
    Gilpin VL; ; ;
    J Vasc Nurs; 2010 Dec; 28(4):154-5. PubMed ID: 21074118
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
    Stavrakis S; Stoner JA; Azar M; Wayangankar S; Thadani U
    Am J Med Sci; 2011 Jan; 341(1):1-9. PubMed ID: 21191260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acetylsalicylic acid for the primary prevention of cardiovascular disease in diabetic patients].
    de Lange DW; Fiets WE; Banga JD
    Ned Tijdschr Geneeskd; 2004 Jul; 148(30):1481-5. PubMed ID: 15481570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin for primary prevention of cardiovascular disease events.
    Nemerovski CW; Salinitri FD; Morbitzer KA; Moser LR
    Pharmacotherapy; 2012 Nov; 32(11):1020-35. PubMed ID: 23019080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin for primary prevention of cardiovascular disease (revisited).
    Med Lett Drugs Ther; 2006 Jul; 48(1238):53. PubMed ID: 16841021
    [No Abstract]   [Full Text] [Related]  

  • 20. The case against routine aspirin use for primary prevention in low-risk adults.
    Bailey AL; Smyth SS; Campbell CL
    Am Fam Physician; 2011 Jun; 83(12):1387-90. PubMed ID: 21671539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.